摘要
目的:观察急性心肌梗死( A M I)患者静脉溶栓前后早期血浆降钙素基因相关肽(c G R P)、内皮素( E T)和血清一氧化氮( N O)水平的变化。方法:采用放射免疫法和比色分析法分别对静脉溶栓前后血管再通组(30 例),与未通组(22 例)的 A M I患者及 20 例正常人上述 3 种血管活性物质进行检测。结果: A M I时患者c G R P 再通组(3864±714)ng/ L,未通组(3298±1007)ng/ L; N O 再通组(1871±356)μm ol/ L,未通组(1485±404)μm ol/ L; E T再通组(13262±3163)ng/ L,未通组(16733±3061)ng/ L;对照组分别为(5294±1417)ng/ L、(2117±634)μm ol/ L和(6665±1063)ng/ L,未通组较再通组变化更为明显。溶栓后12 小时,各组c G R P、 N O 有所回升,但未通组c G R P仍显著低于再通组( P< 005);再通组 E T 继续升高,未通组则开始下降。溶栓后24 小时,2 组c G R P和 N O 继续升高,再通组 E T 下降,未通组则略有升高。结论:血浆c G R P?
Objective:To observe the changes in plasma calcitonin generelated peptide (cGRP),endothelin(ET),and serum nitric oxide (NO) levels before and after thrombolytic therapy in patients with acute myocardial infarction (AMI).Methods:The patients with AMI were divided into two groups:reperfusion group (group A, n =30) and nonreperfusion group (group B, n =22).Immunoradiometric assay was used to measure the plasma cGRP and ET in patients and 20 normal subjects,and colorimetric analysis method was used to measure the serum NO levels.Results:In patients with AMI,plasma cGRP 〔group A and B:(38 64± 7 14)ng/L and (32 98±10 07)ng/L〕and serum NO 〔group A and B:(18 71±3 56)μmol/L and (14 85±4 04)μmol/L〕 levels decreased,while plasma ET 〔group A and B:(132 62±31 63)ng/L and (167 33±30 61)ng/L〕 levels increased compared with normal controls,respectively 〔(52 94±14 17)ng/L,(21 17±6 34)μmol/L,and (66 65±10 63)ng/L〕,and changes in these parameters were more pronounced in group B.At 12 hours after thrombolytic therapy,the levels of cGRP and NO in group A and B were slightly elevated whereas cGRP levels were much lower in group B compared with group A ( P <0 05).In group A,ET levels gradually increased,but it decreased in group B.At 24 hours after thrombolytic therapy,cGRP and NO levels further elevated in both groups.while ET levels decreased in group A with slight increase in group B.The levels of ET in groups A and B were still significantly higher than those of controls ( P <0 01).Conclusions:The plasma cGRP,ET and serum NO may be involved in the pathogenesis of AMI during early stage.The increase of ET and decrease of cGRP and NO within 24 hours of AMI might unfavorably affect for thrombolysis therapy.
出处
《中国危重病急救医学》
CAS
CSCD
1999年第9期520-522,共3页
Chinese Critical Care Medicine
基金
广东省惠州市 1998 年度科技开发项目
关键词
静脉溶栓
心肌梗塞
内皮素
一氧化氮
血管再通
acute myocardial infarction
thrombolytic therapy
calcitonin generelated peptide
endothelin
nitric oxide
vascular reperfusion CLC number:R542.22 Document code:A Artical ID:10030603(1999)09052003